Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Briviact (Brivaracetam) is a prescription anticonvulsant medication manufactured by UCB, Inc. It is FDA-approved as adjunctive therapy for partial-onset (focal) seizures in patients 1 month of age and older. This means Briviact is used alongside other seizure medications to help reduce the frequency of focal seizures.
Briviact is a racetam derivative and a chemical analog of Levetiracetam (Keppra), but it binds to its target — synaptic vesicle glycoprotein 2A (SV2A) — with significantly higher affinity. Many patients who experience behavioral side effects on Levetiracetam find Briviact to be better tolerated.
Briviact works by selectively binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain. SV2A is a protein found on the surface of synaptic vesicles — the tiny packets that store and release neurotransmitters. By binding to SV2A, Briviact modulates neurotransmitter release and reduces neuronal hyperexcitability, which is the underlying driver of seizures.
Briviact has approximately 15–30 times higher affinity for SV2A compared to Levetiracetam, which may contribute to its improved tolerability profile, particularly regarding mood and behavioral side effects. Briviact can be taken with or without food and reaches peak blood levels quickly — within about 1 hour.
The typical dose range is 50 mg to 200 mg per day, taken as 25 mg to 100 mg twice daily. Your neurologist will determine the right dose based on your response and tolerability.
Briviact (Brivaracetam) scores a 55 out of 100 on our findability scale — meaning it can be moderately difficult to locate at your local pharmacy. While there is no formal FDA drug shortage, Briviact is a Schedule V controlled substance and a specialty anticonvulsant that many pharmacies do not routinely stock. Its relatively high cost and niche use for epilepsy mean some pharmacies only order it on request.
A generic brivaracetam oral solution (by Lupin) was approved in February 2026, which should gradually improve availability. However, generic tablets are not yet widely available. If your pharmacy doesn't have Briviact on the shelf, ask them to order it — most can get it within 1–2 business days. You can also use Medfinder to locate pharmacies near you that have it in stock right now.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.
Briviact is most commonly prescribed by:
Because Briviact is a Schedule V controlled substance, any licensed prescriber with DEA authorization can write a prescription. Telehealth options are available for follow-up visits and prescription renewals.
Yes, Briviact is classified as a Schedule V controlled substance by the DEA. Schedule V is the lowest level of federal control, indicating a low potential for abuse relative to Schedule IV drugs. This classification is primarily due to its structural similarity to other racetam compounds.
In practice, the Schedule V classification means your pharmacy may need to order Briviact specifically rather than keeping it on the shelf, and there may be minor additional paperwork involved. However, refill restrictions are minimal compared to higher-schedule medications.
Serious side effects (seek medical attention):
If Briviact is unavailable, too expensive, or not the right fit, your doctor may consider these alternatives for focal seizures:
Major interactions:
Moderate interactions:
Food/drink: Avoid or limit alcohol (increases drowsiness). No significant food interactions — Briviact can be taken with or without meals.
Briviact is an effective anticonvulsant for patients with partial-onset seizures, particularly those who have not responded well to or experienced behavioral side effects with Levetiracetam. While the brand-name price is high ($1,500–$2,000/month), the UCB Savings Card can reduce costs to as little as $10 per fill for commercially insured patients.
A generic oral solution became available in early 2026, and generic tablets are anticipated soon, which should significantly lower out-of-pocket costs. If you're having trouble finding Briviact at your pharmacy, use Medfinder to search for pharmacies that have it in stock near you. And always talk to your neurologist before making any changes to your epilepsy medication regimen.
%2C%20Color%3DOriginal.png)
